Levothyroxine sodium

Product NDC: 70934-897
11-digit product format: 709340897
Labeler code: 70934
Product ID: 70934-897_ccc41a86-ac46-929b-e053-2a95a90a6ba9
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Levothyroxine Sodium
Dosage form: TABLET
Route: ORAL
Labeler: Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Application: ANDA212399
Marketing category: ANDA
Marketing start: 2021-09-24
Marketing end: 0000-00-00
Substance: LEVOTHYROXINE SODIUM
Active strength: 112 ug/1
Pharmacologic classes: l-Thyroxine [EPC],Thyroxine [CS]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	70934-897		D	Discontinued by firm		2026-10-05
excluded package	package	70934-897	70934-897-30	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70934-897-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70934-897-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70934-897-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70934-897-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70934-897-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70934-897-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70934-897-30	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70934-897-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70934-897-30	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	70934-897-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	70934-897-30	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	70934-897-30	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A212399-001	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-002	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-003	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-004	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-005	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-006	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-007	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-008	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-009	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-010	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-011	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-012	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 48 matching rows.

Application-product, TE code table
Application-product	TE code
A212399-001	AB1
A212399-001	AB2
A212399-001	AB3
A212399-001	AB4
A212399-002	AB1
A212399-002	AB2
A212399-002	AB3
A212399-002	AB4
A212399-003	AB1
A212399-003	AB2
A212399-003	AB3
A212399-003	AB4
A212399-004	AB1
A212399-004	AB2
A212399-004	AB3
A212399-004	AB4
A212399-005	AB1
A212399-005	AB2
A212399-005	AB3
A212399-005	AB4
A212399-006	AB1
A212399-006	AB2
A212399-006	AB3
A212399-006	AB4
A212399-007	AB1
A212399-007	AB2
A212399-007	AB3
A212399-007	AB4
A212399-008	AB1
A212399-008	AB2
A212399-008	AB3
A212399-008	AB4
A212399-009	AB1
A212399-009	AB2
A212399-009	AB3
A212399-009	AB4
A212399-010	AB1
A212399-010	AB2
A212399-010	AB3
A212399-010	AB4
A212399-011	AB1
A212399-011	AB2
A212399-011	AB3
A212399-011	AB4
A212399-012	AB1
A212399-012	AB2
A212399-012	AB3
A212399-012	AB4

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 12 · 456 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A212399-001	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-002	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-003	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-004	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-005	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-006	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-007	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-008	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-009	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-010	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-011	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-012	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A212399-001	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-002	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-003	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-004	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-005	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-006	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-007	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-008	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-009	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-010	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-011	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A212399-012	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A212399-001	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-002	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-003	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-004	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-005	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-006	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-007	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-008	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-009	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-010	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-011	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212399-012	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A212399-001	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A212399-002	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A212399-003	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A212399-004	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`31067a03dcf5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 36 · 1,440 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A212399-001	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-001	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-001	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-001	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-002	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-002	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-002	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-002	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-003	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-003	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-003	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-003	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-004	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-004	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-004	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-004	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-005	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-005	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-005	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-005	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-006	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-006	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-006	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-006	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-007	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-007	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-007	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-007	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-008	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-008	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-008	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-008	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-009	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-009	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-009	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-009	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-010	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-010	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-010	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A212399-010	AB4	4	`84e616aacf4f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 4 · 69 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	a0fa8fa5-d3bd-4e52-9ec5-5fb84702826d	2026-03-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	70853a82-ba3b-4663-9f78-6791ca72ba9f	2026-03-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	7c8a6441-3c12-46ae-bb3b-a320d80045b6	2026-03-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	008de8fd-150f-4022-8ccb-c8bfa94875c7	2026-03-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	67f46137-afc4-471b-a6c7-9c2aef92da5d	2026-03-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	PD-Rx Pharmaceuticals, Inc.	70a9bb5c-2259-405e-8d89-cc1db8c70743	2026-02-25	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	PD-Rx Pharmaceuticals, Inc.	6f4998ac-0714-4f5d-8944-9e6902b9f0a6	2026-02-25	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	fa7dd488-de7e-4f9e-87db-18391b723aad	2026-02-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	4520fae0-acce-47a0-af9e-f4f16ea6b268	2026-02-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	2ce47caf-6ece-429c-b5d7-c47ba6952800	2026-02-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	ASCLEMED USA INC.	42a26f8a-dc67-42e4-abb0-d2602afb1b7d	2026-02-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	b717aff6-f754-458d-be87-d12d87c5da00	2026-02-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	62de26a8-d6fc-463f-abe6-4656228c3142	2026-02-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	36af0286-e447-4098-b3f2-772debd58667	2026-01-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	e8142948-2bde-4f4b-931e-da43e91f2d59	2026-01-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	d29bc0fd-5587-4a70-a505-f5aee1f115a6	2026-01-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	d5b11dac-1acd-4aa2-b837-e3b90d4f6922	2026-01-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Northwind Health Company, LLC	db998119-a293-3568-e053-2995a90ac47a	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Northwind Health Company, LLC	da570872-94a1-4852-e053-2995a90aacb6	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Northwind Health Company, LLC	da827567-810b-624d-e053-2a95a90a9bde	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9J765S329G	LEVOTHYROXINE SODIUM	6106-07-6	LEVOTHYROXINE SODIUM

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70934-897-30	70934089730	30 TABLET in 1 BOTTLE, PLASTIC (70934-897-30)	30 tablet	2021-09-24	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Levothyroxine sodium	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	2022-01-04	HUMAN PRESCRIPTION DRUG LABEL	1